Edition:
United Kingdom

Kaustubh Kulkarni

Hope fades for 18 on submarine after blasts, fire

14 Aug 2013

MUMBAI India's navy chief held out little hope for survivors on a submarine after some of its weapons detonated accidentally and fire swept through it. The likely deaths and damage are the worst blow to the navy since a 1971 war with Pakistan.

Hope fades for 18 on Indian submarine after blasts, fire

14 Aug 2013

MUMBAI India's navy chief held out little hope for survivors on a submarine after some of its weapons detonated accidentally and fire swept through it. The likely deaths and damage are the worst blow to the navy since a 1971 war with Pakistan. | Video

Hope fades for 18 on Indian submarine after blasts, fire

14 Aug 2013

MUMBAI India's navy chief held out little hope for survivors on a submarine after some of its weapons detonated accidentally and fire swept through it. The likely deaths and damage are the worst blow to the navy since a 1971 war with Pakistan. | Video

India revokes patents on Allergan eye drugs Ganfort and Combigan

08 Aug 2013

MUMBAI India revoked patents on two of Allergan Inc's eye drugs on Thursday, the latest in a series of intellectual property setbacks suffered by Western drugmakers.

India revokes patents on Allergan eye drugs Ganfort and Combigan

08 Aug 2013

MUMBAI India revoked patents on two of Allergan Inc's eye drugs on Thursday, the latest in a series of intellectual property setbacks suffered by Western drugmakers.

India revokes patents on Allergan eye drugs Ganfort and Combigan

08 Aug 2013

MUMBAI, Aug 8 India revoked patents on two of Allergan Inc's eye drugs on Thursday, the latest in a series of intellectual property setbacks suffered by Western drugmakers.

India revokes GSK cancer drug patent in Pharma blow

03 Aug 2013

MUMBAI India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that was a blow to global pharmaceutical firms.

India revokes GSK cancer drug patent in latest Big Pharma blow

02 Aug 2013

MUMBAI India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that was a blow to global pharmaceutical firms.

India revokes GSK cancer drug patent in latest Big Pharma blow

02 Aug 2013

MUMBAI India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that was a blow to global pharmaceutical firms.

India revokes GSK cancer drug patent in latest Big Pharma blow

02 Aug 2013

MUMBAI India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental innovations that was a blow to global pharmaceutical firms.

World News